This HTML5 document contains 91 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q81056919
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en marzu de 2008 наукова стаття, опублікована в березні 2008 scientific article published on 20 March 2008 im März 2008 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel article scientifique publié en 2008
p:P577
wds:Q81056919-08603F0B-27EB-456C-A5D6-D14603E25576
wdt:P577
2008-03-20T00:00:00Z
p:P2860
wds:Q81056919-71E688E1-34D8-4253-9495-F5869115CBFC wds:Q81056919-78841502-9386-4E87-BCDC-28553A3B77FC wds:Q81056919-78F5106B-279B-4562-96CD-980CD30EBE5F wds:Q81056919-951CED38-BBA9-4EEA-9071-76057A1171DB wds:Q81056919-C277D054-6C38-4B82-9C72-54B0D16728B4 wds:Q81056919-D70A4D49-9F79-4640-9676-8C251BCAE1FC wds:Q81056919-B7154054-EA9A-4787-BC6B-22ECD322DB0B wds:Q81056919-C0248C85-1B12-4A19-804F-6D3EA515E8AE wds:Q81056919-E494490E-42B2-46A0-8BFA-DE11BF619EBC wds:Q81056919-E9E7D0F2-46F1-4EF1-A190-FB3D6DFE0BD5 wds:Q81056919-EBE721D4-6800-49B7-B927-AAD36185B441 wds:Q81056919-D8E7AEDA-EEA6-41E9-907A-DFED0B44279A wds:Q81056919-FDC60060-6F01-49F6-9369-D84A40E4D436 wds:Q81056919-FEF275B4-EB94-42B6-90E7-02AD43787A4C wds:Q81056919-00F16F2A-5066-41FE-80B6-F078945D9454 wds:Q81056919-5D86C50C-8DD0-49F2-BF5A-E1F3F2F63CA2 wds:Q81056919-67B60D92-C484-44A9-937F-C1D4E025EAC1 wds:Q81056919-1FA79703-5762-481D-858F-FEE22F67B4E2 wds:Q81056919-48BCD159-945A-40CA-B17F-02CAA8F26608 wds:Q81056919-95B78922-60B5-4801-8DFD-30E1A6F8C332 wds:Q81056919-99C45EE6-3AF4-4F75-A66A-2038E09EE3F7 wds:Q81056919-B45DE2D9-B08F-4964-BC26-5B3E8100B4FC
wdt:P2860
wd:Q83863803 wd:Q33818183 wd:Q44143102 wd:Q74060242 wd:Q41905442 wd:Q78144237 wd:Q50615631 wd:Q57954174 wd:Q52064615 wd:Q52364585 wd:Q37334447 wd:Q50688310 wd:Q71775133 wd:Q60360652 wd:Q61835866 wd:Q73370813 wd:Q71916845 wd:Q22253018 wd:Q81210757 wd:Q74295926 wd:Q52045321 wd:Q34568213
p:P2093
wds:Q81056919-97A68E3A-0F48-493D-A93F-79E31352766E wds:Q81056919-1B780ECE-6B13-42BD-A2D7-BD54B646CB93
wdt:P2093
Anette Siedler Helen Kalies
rdfs:label
Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure
skos:prefLabel
Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure
schema:name
Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure
p:P50
wds:Q81056919-C70902DE-9FC7-4A1D-B75D-23462B0B70AA wds:Q81056919-1F1AF630-ECBA-4DB7-B863-1A949E310B04 wds:Q81056919-4E56F429-7F0B-4FE7-8CBF-E1C50B720C97 wds:Q81056919-67E22896-48DF-48AC-A1C3-7330B7F231AD
wdt:P50
wd:Q122887961 wd:Q124719070 wd:Q42884415 wd:Q104783566
p:P1476
wds:Q81056919-B7D7D700-D33D-4EB2-9970-CD7F6044DC90
wdt:P1476
Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure
p:P304
wds:Q81056919-4EDDCA63-303D-4988-A514-B2A02E0EEFF5
wdt:P304
2545-2552
p:P31
wds:Q81056919-DEA32015-023B-473B-AC80-711F5A1A68CE
wdt:P31
wd:Q13442814
p:P921
wds:Q81056919-E6FC090D-05ED-4212-B783-350D6449413E
wdt:P921
wd:Q1141979
p:P698
wds:Q81056919-F08AEADE-E373-4BEF-A14C-AF3B4AF52E07
wdtn:P698
n9:18403069
wdt:P698
18403069
p:P1433
wds:Q81056919-C967BDFB-4800-4BD7-B1DD-EA4A9657AB4C
wdt:P1433
wd:Q7907941
p:P433
wds:Q81056919-C0204300-0E87-485C-9472-B38103A33C4D
p:P478
wds:Q81056919-DAAC9D7B-5C9C-4466-B859-BDF26A522D9A
wdt:P433
20
wdt:P478
26
p:P356
wds:Q81056919-DF6234AA-5FA4-4092-B463-CA85C7EEBE54
wdtn:P356
n8:J.VACCINE.2008.03.001
wdt:P356
10.1016/J.VACCINE.2008.03.001